Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: An update

American Journal of Kidney Diseases

Volumn 66, Issue 1, 2015, Pages 172-173

  Ardissino, Gianluigi ^a   Possenti, Ilaria ^a   Tel, Francesca ^a   Testa, Sara ^a   Salardi, Stefania ^a   Ladisa, Vito ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ECULIZUMAB; ANTIBODIES, MONOCLONAL, HUMANIZED;

CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FOLLOW UP; HEMOLYTIC UREMIC SYNDROME; HUMAN; LETTER; PROTEINURIA; RELAPSE; REMISSION; RENAL REPLACEMENT THERAPY; TREATMENT WITHDRAWAL; ATYPICAL HEMOLYTIC UREMIC SYNDROME; COST OF ILLNESS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEMOGLOBINURIA; HUMANS; MALE; QUALITY OF LIFE; WITHHOLDING TREATMENT;

ANTIBODIES, MONOCLONAL, HUMANIZED; ATYPICAL HEMOLYTIC UREMIC SYNDROME; COST OF ILLNESS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEMOGLOBINURIA; HUMANS; MALE; QUALITY OF LIFE; WITHHOLDING TREATMENT;

EID: 84937413194     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.04.010     Document Type: Letter

References (2)

1. G. Ardissino, S. Testa, I. Possenti, and et al. Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases Am J Kidney Dis 64 4 2014 633 637
2. M. Cugno, R. Gualtierotti, I. Possenti, and et al. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome J Thromb Haemost 12 9 2014 1440 1448